CHEMED CORP
For the period ended Dec 31, 2024. Filed Feb 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 28, 2025
CHE$538.06+1.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| CONSOLIDATED BALANCE SHEETS | ||
|---|---|---|
| Chemed Corporation and Subsidiary Companies | ||
| (in thousands, except shares and per share data) | ||
| December 31, | 2024 | 2023 |
| Assets | ||
| Current assets | ||
| Cash and cash equivalents (Note 9) | $178,350 | $263,958 |
| Accounts receivable | 171,163 | 181,511 |
| Inventories | 8,193 | 12,004 |
| Prepaid income taxes | 11,068 | 13,166 |
| Prepaid expenses | 25,974 | 30,204 |
| Total current assets | 394,748 | 500,843 |
| Investments of deferred compensation plans held in trust (Notes 15 and 17) | 130,960 | 106,126 |
| Properties and equipment, at cost, less accumulated depreciation (Note 13) | 200,837 | 203,840 |
| Lease right of use asset (Note 14) | 127,323 | 126,387 |
| Identifiable intangible assets less accumulated amortization (Note 6) | 92,206 | 90,264 |
| Goodwill | 666,744 | 585,017 |
| Other assets (Note 12) | 55,757 | 55,618 |
| Total Assets | $1,668,575 | $1,668,095 |
| Liabilities | ||
| Current liabilities | ||
| Accounts payable | $44,146 | $64,034 |
| Income taxes (Note 11) | 7,593 | 6,858 |
| Accrued insurance | 56,703 | 58,568 |
| Accrued compensation | 92,073 | 88,381 |
| Short-term lease liability (Note 14) | 42,306 | 38,635 |
| Other current liabilities (Note 21) | 42,874 | 55,574 |
| Total current liabilities | 285,695 | 312,050 |
| Deferred income taxes (Note 11) | 25,945 | 30,321 |
| Deferred compensation liabilities (Note 15) | 126,035 | 104,069 |
| Long-term lease liability (Note 14) | 98,538 | 100,776 |
| Other liabilities | 13,369 | 13,003 |
| Total Liabilities | 549,582 | 560,219 |
| Commitments and contingencies (Note 18) | ||
| Stockholders' Equity | ||
| Capital stock - authorized 80,000,000 shares $1 par; issued 37,422,348 shares | ||
| (2023 - 37,183,681 shares) | 37,422 | 37,184 |
| Paid-in capital | 1,484,176 | 1,341,273 |
| Retained earnings | 2,721,832 | 2,446,925 |
| Treasury stock - 22,865,842 shares (2023 - 22,148,927 shares), at cost | (3,126,660) | (2,719,588) |
| Deferred compensation payable in Company stock (Note 15) | 2,223 | 2,082 |
| Total Stockholders' Equity | 1,118,993 | 1,107,876 |
| Total Liabilities and Stockholders' Equity | $1,668,575 | $1,668,095 |
| The Notes to Consolidated Financial Statements are integral parts of these statements. | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.